Literature DB >> 26671115

Natalizumab continuation during pregnancy in a patient with previous severe IRIS syndrome.

M Théaudin1, E Elefant2, M V Senat3.   

Abstract

Entities:  

Keywords:  Multiple sclerosis; Natalizumab; Pregnancy

Mesh：

Substances：

Year:  2015        PMID： 26671115     DOI： 10.1016/j.jns.2015.10.047

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  3 in total

Review 1.  Managing IBD Therapies in Pregnancy.

Authors:  Jill K J Gaidos; Sunanda V Kane
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

2.  Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivation.

Authors:  Jessica Frau; Giancarlo Coghe; Giuseppe Fenu; Lorena Lorefice; Eleonora Cocco
Journal:  Neurol Sci       Date:  2017-10-07       Impact factor: 3.307

Review 3.  An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.

Authors:  Caila Vaughn; Aisha Bushra; Channa Kolb; Bianca Weinstock-Guttman
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.